NO20006604D0 - Methods and transdermal compositions for pain relief - Google Patents
Methods and transdermal compositions for pain reliefInfo
- Publication number
- NO20006604D0 NO20006604D0 NO20006604A NO20006604A NO20006604D0 NO 20006604 D0 NO20006604 D0 NO 20006604D0 NO 20006604 A NO20006604 A NO 20006604A NO 20006604 A NO20006604 A NO 20006604A NO 20006604 D0 NO20006604 D0 NO 20006604D0
- Authority
- NO
- Norway
- Prior art keywords
- methods
- pain relief
- transdermal compositions
- transdermal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/106,684 US6290986B1 (en) | 1996-10-24 | 1998-06-29 | Method and composition for transdermal administration of pharmacologic agents |
US12290399P | 1999-03-05 | 1999-03-05 | |
PCT/US1999/014653 WO2000000120A1 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20006604D0 true NO20006604D0 (en) | 2000-12-22 |
NO20006604L NO20006604L (en) | 2001-02-28 |
Family
ID=26803907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20006604A NO20006604L (en) | 1998-06-29 | 2000-12-22 | Methods and transdermal compositions for pain relief |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1093348A4 (en) |
JP (1) | JP2002519310A (en) |
KR (1) | KR20010078754A (en) |
CN (1) | CN1331576A (en) |
AU (1) | AU4841599A (en) |
BG (1) | BG105175A (en) |
BR (1) | BR9912508A (en) |
CA (1) | CA2335837A1 (en) |
HR (1) | HRP20000905A2 (en) |
HU (1) | HUP0102728A3 (en) |
ID (1) | ID28213A (en) |
IL (1) | IL140420A0 (en) |
MX (1) | MXPA00012767A (en) |
NO (1) | NO20006604L (en) |
PL (1) | PL345216A1 (en) |
SK (1) | SK20012000A3 (en) |
TR (1) | TR200003801T2 (en) |
WO (1) | WO2000000120A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
EP0986540B1 (en) | 1997-04-22 | 2005-02-16 | Euro-Celtique S.A. | The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
ES2246485T3 (en) | 1999-07-01 | 2006-02-16 | PHARMACIA & UPJOHN COMPANY LLC | (S, S) -REBOXETINE TO TREAT INCONTINENCE. |
EP1459750B1 (en) * | 1999-07-01 | 2005-06-01 | Pharmacia & Upjohn Company LLC | (S,S)-reboxetine for treating fibromyalgia and other somatoform disorders |
CA2325106A1 (en) * | 1999-12-06 | 2001-06-06 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
IN191512B (en) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
DE10032132A1 (en) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition |
DE10042412B4 (en) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transceiver for bus subscriber of bus system of building system engineering, has two wires, where microcontroller is connected with receiver unit over connection on one hand, which is connected to two wires of bus system |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
WO2004054542A2 (en) | 2002-12-13 | 2004-07-01 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
JP2005154368A (en) * | 2003-11-27 | 2005-06-16 | Teikoku Seiyaku Co Ltd | Analgesic agent for neuropathic pain containing disopyramide |
JP4807721B2 (en) * | 2004-01-29 | 2011-11-02 | 株式会社 メドレックス | Anti-inflammatory analgesic topical |
ES2602273T3 (en) | 2004-09-17 | 2017-02-20 | Durect Corporation | Prolonged local anesthetic composition containing Saib |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
JP2007308403A (en) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | Skin care preparation |
KR100880748B1 (en) * | 2006-08-29 | 2009-02-02 | 정헌택 | Pharmaceutical composition containing demethoxycurcumin to prevent restenosis |
PL2117521T3 (en) | 2006-11-03 | 2012-11-30 | Durect Corp | Transdermal delivery systems comprising bupivacaine |
US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
WO2009075782A1 (en) | 2007-12-06 | 2009-06-18 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
EP2428211A4 (en) * | 2009-05-07 | 2013-04-03 | Moon & J Inc | Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
WO2014144975A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
CA2939562C (en) * | 2014-02-11 | 2023-02-14 | Dr. Reddy's Laboratories Ltd. | Parenteral compositions of celecoxib |
WO2020084548A1 (en) | 2018-10-26 | 2020-04-30 | Viramal Limited | Mucoadhesive gel composition |
ES2948955T3 (en) | 2018-11-30 | 2023-09-22 | Viramal Ltd | A method of preparing a gelling agent, the gelling agent thus obtained and the use of said gelling agent |
KR20220140711A (en) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods |
FR3108841B1 (en) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4395420A (en) * | 1981-12-09 | 1983-07-26 | Bernstein Joel E | Method and composition for treating pruritis |
SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US5885597A (en) * | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
-
1999
- 1999-06-29 BR BR9912508-0A patent/BR9912508A/en not_active Application Discontinuation
- 1999-06-29 IL IL14042099A patent/IL140420A0/en unknown
- 1999-06-29 PL PL99345216A patent/PL345216A1/en unknown
- 1999-06-29 CA CA002335837A patent/CA2335837A1/en not_active Abandoned
- 1999-06-29 CN CN99810055A patent/CN1331576A/en active Pending
- 1999-06-29 TR TR2000/03801T patent/TR200003801T2/en unknown
- 1999-06-29 MX MXPA00012767A patent/MXPA00012767A/en unknown
- 1999-06-29 HU HU0102728A patent/HUP0102728A3/en unknown
- 1999-06-29 JP JP2000556706A patent/JP2002519310A/en active Pending
- 1999-06-29 ID IDW20010231A patent/ID28213A/en unknown
- 1999-06-29 KR KR1020007014985A patent/KR20010078754A/en not_active Application Discontinuation
- 1999-06-29 SK SK2001-2000A patent/SK20012000A3/en unknown
- 1999-06-29 AU AU48415/99A patent/AU4841599A/en not_active Abandoned
- 1999-06-29 WO PCT/US1999/014653 patent/WO2000000120A1/en not_active Application Discontinuation
- 1999-06-29 EP EP99932017A patent/EP1093348A4/en not_active Withdrawn
-
2000
- 2000-12-22 NO NO20006604A patent/NO20006604L/en not_active Application Discontinuation
- 2000-12-28 HR HR20000905A patent/HRP20000905A2/en not_active Application Discontinuation
-
2001
- 2001-01-24 BG BG105175A patent/BG105175A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20006604L (en) | 2001-02-28 |
CN1331576A (en) | 2002-01-16 |
WO2000000120A1 (en) | 2000-01-06 |
EP1093348A4 (en) | 2003-07-16 |
JP2002519310A (en) | 2002-07-02 |
MXPA00012767A (en) | 2002-08-09 |
IL140420A0 (en) | 2002-02-10 |
CA2335837A1 (en) | 2000-01-06 |
SK20012000A3 (en) | 2001-08-06 |
EP1093348A1 (en) | 2001-04-25 |
AU4841599A (en) | 2000-01-17 |
HRP20000905A2 (en) | 2001-08-31 |
BR9912508A (en) | 2001-05-02 |
KR20010078754A (en) | 2001-08-21 |
HUP0102728A2 (en) | 2002-03-28 |
HUP0102728A3 (en) | 2002-12-28 |
TR200003801T2 (en) | 2001-06-21 |
ID28213A (en) | 2001-05-10 |
WO2000000120A9 (en) | 2000-03-30 |
PL345216A1 (en) | 2001-12-03 |
BG105175A (en) | 2001-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20006604D0 (en) | Methods and transdermal compositions for pain relief | |
AU2002234192A8 (en) | Methods and transdermal compositions for pain relief | |
NO20003096D0 (en) | Compositions and Methods for Treating ADD | |
DK0811006T3 (en) | Benzopyran-containing compounds and methods for their use | |
DK1242095T3 (en) | Antimicrobial compositions and methods for their use | |
IS5341A (en) | Combination therapy containing atorvastatin and antihypertensive agent | |
IS5928A (en) | Methods and combinations to prevent drug resistance | |
NO973464D0 (en) | Extension tube - scraper plug and method | |
NO20005017D0 (en) | Methods and viscous compositions for treating wells | |
NO20001323D0 (en) | Dipeptide-apoptosis inhibitors and their use | |
NO20006488D0 (en) | Composition and application | |
NO20003067L (en) | Antipicornavirus compounds and methods for their use and preparation | |
DK1112003T3 (en) | New composition and application | |
NO983576L (en) | Well treatment fluids and methods | |
NO984836L (en) | Substituted benzylamines and their use in the treatment of depression | |
NO20010464D0 (en) | Methods and compositions for the treatment of gastroesophrageal reflux syndrome | |
NO20013085D0 (en) | Phosphorus-organic compounds and their use | |
DE69920224D1 (en) | Urea derivatives for pain relief | |
NO20005763L (en) | DHEA composition and method | |
NO20010248L (en) | Transdermal patch and topical compositions comprising propylnorapomorphine | |
NO20001758D0 (en) | Methods and compositions for the treatment of arthritis | |
DK0915655T3 (en) | Method and composition for the treatment of parasites in animal environments | |
NO983556D0 (en) | Formulation and application | |
NO20022990L (en) | Method and composition for the treatment of pain | |
AU5169200A (en) | Methods and compositions for treating breakthrough pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |